TipRanks on MSN
Ascentage Pharma advances olverembatinib with new liver function study, offering gradual upside for investors
Ascentage Pharma Group International ($HK:6855) announced an update on their ongoing clinical study. Study Overview The trial, officially titled ...
Ten minutes of running with moderate intensity benefits pleasure levels and boosts brain function, according to researchers. In a study published in the journal Scientific Reports, a team of ...
While early poverty in the household is already associated with impaired brain development among kids, a new study takes it further, linking impoverished neighborhoods to kids' smaller brain volumes ...
WASHINGTON, DC—Additional evidence, this time from a phase IIb trial in healthy people ages 50 to 80, supports that bentracimab (PhaseBio) provides a near-immediate reversal of ticagrelor’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results